Cholesterol Metabolism: A Double-Edged Sword in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) represents a leading cause of cancer-related deaths globally. The rising incidence of metabolic syndrome and its hepatic manifestation, nonalcoholic fatty liver disease (NAFLD), have emerged as the fastest-growing cause of HCC in recent years. Cholesterol, a major lipi...
Enregistré dans:
Auteurs principaux: | Fangli Zhou, Xiaoli Sun |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ec1a279226d34e76a9dd84f9878f95aa |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis
par: Filip R, et autres
Publié: (2018) -
Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
par: Apollinariya V. Bogolyubova, et autres
Publié: (2017) -
Biochanin A Regulates Cholesterol Metabolism Further Delays the Progression of Nonalcoholic Fatty Liver Disease
par: Fan Y, et autres
Publié: (2021) -
Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice
par: Masahiro Matsui, et autres
Publié: (2021) -
Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?
par: Ekaterina E. Mishina, et autres
Publié: (2017)